MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cardiovascular Systems Company Profile (NASDAQ:CSII)

Consensus Ratings for Cardiovascular Systems (NASDAQ:CSII) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $20.00 (15.14% upside)

Analysts' Ratings History for Cardiovascular Systems (NASDAQ:CSII)
Show:
DateFirmActionRatingPrice TargetActions
5/7/2016Leerink SwannReiterated RatingMarket Perform$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Needham & Company LLCBoost Price TargetBuy$16.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2015Northcoast ResearchInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Feltl & Co.DowngradeStrong-Buy -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Dougherty & CoLower Price TargetBuy$50.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Benchmark Co.Lower Price TargetBuy$49.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Bank of AmericaDowngradeNeutral -> Underperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Cardiovascular Systems (NASDAQ:CSII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/4/2016Q316($0.54)($0.31)$42.13 million$44.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/21/2016Q216($0.50)($0.47)$44.82 million$41.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q116($0.42)($0.41)$43.90 million$43.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q415($0.30)($0.27)$50.10 million$48.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q315($0.34)($0.34)$46.84 million$47.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q215($0.35)($0.17)$43.97 million$44.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q115($0.33)($0.26)$40.24 million$41.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.28)($0.31)$37.21 million$39.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114($0.32)($0.32)$34.15 million$34.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2014Q2($0.34)($0.32)$30.62 million$32.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q4 2013($0.30)($0.28)$27.18 million$28.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Cardiovascular Systems (NASDAQ:CSII)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165($0.61)($0.27)($0.44)
Q2 20164($0.50)($0.23)($0.40)
Q3 20165($0.51)($0.33)($0.41)
Q4 20165($0.47)($0.20)($0.34)
Q1 20175($0.44)($0.21)($0.31)
Q2 20175($0.37)($0.18)($0.27)
Q3 20172($0.19)($0.15)($0.17)
Q4 20172($0.17)($0.12)($0.15)
(Data provided by Zacks Investment Research)
Dividend History for Cardiovascular Systems (NASDAQ:CSII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cardiovascular Systems (NASDAQ:CSII)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/23/2016Camber Capital Management LlcMajor ShareholderBuy250,000$7.55$1,887,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/25/2016Scott R WardCEOBuy2,700$9.30$25,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2015Robert J. ThatcherinsiderSell64,700$16.31$1,055,257.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015David MartinCEOSell19,646$23.81$467,771.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Kevin J KennyCOOSell5,289$23.85$126,142.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Laurence L BetterleyCFOSell9,597$23.96$229,944.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Paul A KoehnSVPSell4,946$23.86$118,011.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Robert J ThatcherInsiderSell5,282$23.85$125,975.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015David MartinCEOSell17,688$23.99$424,335.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Kevin J. KennyCOOSell3,913$24.00$93,912.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Laurence L BetterleyCFOSell8,476$24.00$203,424.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Paul A. KoehnSVPSell4,402$23.99$105,603.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Robert J. ThatcherinsiderSell2,960$23.99$71,010.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Brent G BlackeyDirectorBuy2,500$22.74$56,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Paul A KoehnSVPSell4,389$27.86$122,277.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015Brent G BlackeyDirectorBuy2,500$29.38$73,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015David MartinCEOSell7,500$35.85$268,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015David MartinCEOSell4,500$34.96$157,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Kevin J KennyVPSell4,212$35.00$147,420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014David MartinCEOSell10,248$28.85$295,654.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Kevin J KennyVPSell3,528$28.85$101,782.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Laurence L BetterleyCFOSell4,674$28.82$134,704.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Paul A KoehnSVPSell2,612$28.85$75,356.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Robert J ThatcherInsiderSell2,791$28.85$80,520.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014Paul A KoehnSVPSell1,315$28.82$37,898.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014David MartinCEOSell13,957$29.03$405,171.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Kevin J KennyVPSell2,914$29.09$84,768.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Laurence L BetterleyCFOSell6,578$29.02$190,893.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Paul A KoehnSVPSell2,755$29.06$80,060.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Robert J ThatcherInsiderSell3,225$29.06$93,718.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014David MartinCEOSell11,754$29.28$344,157.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Kevin J KennyVPSell2,117$29.28$61,985.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Laurence L BetterleyCFOSell5,725$29.28$167,628.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Paul A KoehnSVPSell2,168$29.28$63,479.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Robert J ThatcherInsiderSell2,537$29.28$74,283.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014David MartinCEOSell10,703$28.83$308,567.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014Kevin J KennyVPSell3,007$28.83$86,691.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014Laurence L BetterleyCFOSell3,984$28.83$114,858.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014Paul A KoehnSVPSell2,716$28.83$78,302.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014Robert J ThatcherInsiderSell2,939$28.83$84,731.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2014Kevin KennyVPSell15,484$28.79$445,784.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014David MartinCEOSell29,200$37.31$1,089,452.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Kevin KennyVPSell6,779$36.02$244,179.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2014David MartinCEOSell50,000$35.12$1,756,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2014Robert ThatcherVPSell35,139$35.06$1,231,973.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/22/2013Robert ThatcherVPSell22,384$32.82$734,642.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2013James E FlahertyInsiderSell34,819$30.35$1,056,756.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2013David MartinCEOSell154,080$27.73$4,272,638.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2013James E FlahertyInsiderSell36,682$26.85$984,911.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2013Robert J ThatcherVPSell23,426$28.19$660,378.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2013Kevin J KennyVPSell5,608$27.31$153,154.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/16/2013Kevin J KennyVPSell4,182$22.95$95,976.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2013David MartinCEOSell21,170$22.00$465,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013David MartinCEOSell6,702$20.24$135,648.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013James FlahertyInsiderSell2,066$20.28$41,898.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Robert ThatcherVPSell1,274$20.28$25,836.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013Laurence BetterleyCFOSell2,694$20.32$54,742.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013Paul KoehnSVPSell1,094$20.32$22,230.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013David MartinCEOSell8,030$20.94$168,148.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013James FlahertyInsiderSell2,970$20.94$62,191.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Laurence BetterleyCFOSell4,324$20.93$90,501.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Paul KoehnSVPSell1,732$20.93$36,250.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Robert ThatcherVPSell1,731$20.94$36,247.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013John FriedmanDirectorSell48,273$20.73$1,000,699.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013David MartinCEOSell21,552$20.64$444,833.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013James FlahertyInsiderSell7,165$20.64$147,885.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Kevin KennyVPSell1,899$20.64$39,195.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Laurence BetterleyCFOSell8,692$20.64$179,402.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013David MartinCEOSell27,229$21.07$573,715.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013James FlahertyInsiderSell9,051$21.07$190,704.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013Kevin KennyVPSell2,396$21.07$50,483.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013Laurence BetterleyCFOSell10,982$21.07$231,390.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013James FlahertyInsiderSell1,255$20.51$25,740.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Laurence BetterleyCFOSell1,568$20.51$32,159.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013James FlahertyInsiderSell4,902$21.31$104,461.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Kevin KennyVPSell2,529$21.20$53,614.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013James FlahertyInsiderSell19,649$22.27$437,583.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013David MartinCEOSell11,094$19.69$218,440.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Laurence L BetterleyCFOSell6,579$19.72$129,737.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Robert J ThatcherVPSell3,112$19.86$61,804.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013James E FlahertyInsiderSell10,000$21.00$210,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Paul A KoehnVPSell2,472$20.00$49,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Kevin J KennyVPSell4,182$19.95$83,430.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Glen D NelsonDirectorBuy10,250$18.47$189,317.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Glen D NelsonDirectorBuy4,753$18.93$89,974.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Glen D NelsonDirectorBuy18,393$18.11$333,097.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2012Glen D NelsonDirectorBuy33,000$11.96$394,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012David MartinCEOSell10,510$9.07$95,325.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012James E FlahertyInsiderSell4,018$9.07$36,443.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012Laurence L BetterleyCFOSell4,770$9.07$43,263.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012Paul A KoehnVPSell2,496$9.07$22,638.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Cardiovascular Systems (NASDAQ:CSII)
DateHeadline
06/28/16 04:01 PMCARDIOVASCULAR SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E -
06/28/16 03:24 PMCardiovascular Systems, Inc. (NASDAQ:CSII) Target Price Is $16.6 - RealistInvestor.com
06/26/16 03:08 PMStrong Sell Calls Recommendations For Cardiovascular Systems, Inc. (NASDAQ:CSII) At 0 - Investor Newswire
06/24/16 10:07 AMCardiovascular Systems, Inc. (NASDAQ:CSII) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 08:55 AMCardiovascular Systems Inc. (NASDAQ:CSII) Upside Stock Momentum at EXTREME Strength - CML News
06/21/16 08:09 AMCardiovascular Systems, Inc. (NASDAQ:CSII): Growth Forecast - RealistInvestor.com
06/20/16 09:45 AMStrong Buy Calls Count For Cardiovascular Systems, Inc. (NASDAQ:CSII) At 2 - Investor Newswire
06/12/16 03:23 PMTrend Of Rating Given To Cardiovascular Systems, Inc. (NASDAQ:CSII) - Investor Newswire
06/09/16 09:29 PMFDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility - [at noodls] - June 10, 2016 Tokyo Japan - June 10, 2016 - Terumo Corporation announced that Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully ...
06/08/16 11:06 AMCARDIOVASCULAR SYSTEMS INC. (NASDAQ:CSII) Financial Condition Compared to S&P 500 - CML News
06/06/16 05:40 AMPerformance Review for Cardiovascular Systems Inc. (NASDAQ:CSII) - HNN
06/03/16 03:35 PMBroker Watchlist: Cardiovascular Systems, Inc. (NASDAQ:CSII) - Share Trading News
06/02/16 10:29 AMCardiovascular Systems Incorporated (NASDAQ:CSII) Shorted Shares Increased 4.17% After Market Selling - HNN - Cardiovascular Systems Incorporated (NASDAQ:CSII) Shorted Shares Increased 4.17% After Market SellingHNNCardiovascular Systems Inc (NASDAQ:CSII) has risen 28.21% since October 26, 2015 and is uptrending. It has outperformed by 27.16% the S&P500. Cardiovascular Systems, Inc. is a medical technology company. The company has a market cap of $559.60 ...Investor News: Certain Directors of Cardiovascular Systems Inc (NASDAQ:CSII) are under InvestigationGroundReportall 2 news articles »
06/01/16 09:38 PMInvestor News: Certain Directors of Cardiovascular Systems Inc (NASDAQ:CSII) are under Investigation - GroundReport - Investor News: Certain Directors of Cardiovascular Systems Inc (NASDAQ:CSII) are under InvestigationGroundReportAn investigation for investors in NASDAQ:CSII shares concerning potential breaches of fiduciary duties by certain directors of Cardiovascular Systems Inc was announced. Investors who are current long term investors in Cardiovascular Systems Inc ...
06/01/16 03:37 PMInvestor News: Certain Directors of Cardiovascular Systems Inc (NASDAQ:CSII) are under Investigation - An investigation for investors in NASDAQ:CSII shares concerning potential breaches of fiduciary duties by certain directors of Cardiovascular Systems Inc was announced. Investors who are current long term investors in Cardiovascular Systems Inc (NASDAQ ...
05/26/16 04:22 PMCARDIOVASCULAR SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers -
05/26/16 05:23 AMCardiovascular Systems, Inc. (NASDAQ:CSII) Yearly EPS Forecast At $-0.12 - Investor Newswire - Cardiovascular Systems, Inc. (NASDAQ:CSII) Yearly EPS Forecast At $-0.12Investor NewswireAs of 2017-06-30, Zacks released EPS target of $-0.12 for Cardiovascular Systems, Inc. (NASDAQ:CSII) for the year ended 2017. Median EPS forecast is at $-0.105. The forecast is based on calls of 4 brokerages. Also, 3 research reports were studied to ...and more »
05/26/16 05:23 AMInsiders Are Gradually Buying Cardiovascular Systems Inc. (NASDAQ:CSII) - Wall Street Hints and News - Insiders Are Gradually Buying Cardiovascular Systems Inc. (NASDAQ:CSII)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Cardiovascular Systems Inc. (NASDAQ:CSII) have increased their position in the stock by 25.03% over the past 6 months. Insiders now own 4.01% of total outstanding shares. There are both legal and illegal ...and more »
05/25/16 11:53 AMCardiovascular Systems Inc (NASDAQ:CSII) Long Term Investor Alert: Investigation of Potential Wrongdoing - An investigation on behalf of current long term investors in Cardiovascular Systems Inc (NASDAQ:CSII) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ:CSII stockholders should contact the ...
05/21/16 11:45 AMCardiovascular Systems, Inc. (NASDAQ:CSII) Quarterly EPS Projection At $-0.2 - RealistInvestor.com - Cardiovascular Systems, Inc. (NASDAQ:CSII) Quarterly EPS Projection At $-0.2RealistInvestor.comA week earlier, the EPS projection was $-0.2 while 30-days ago it was $-0.2. This target was set at $-0.2 60 days ago and it was $-0.2 90 days earlier. From a week ago, the change in estimates is 0%. EPS was revised 0 times up and 0 down in last one week.and more »
05/20/16 12:09 PMInsiders Are Buying Cardiovascular Systems Inc. (NASDAQ:CSII) - Wall Street Hints and News - Insiders Are Buying Cardiovascular Systems Inc. (NASDAQ:CSII)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Cardiovascular Systems Inc. (NASDAQ:CSII) have increased their position in the stock by 24.52%. Insiders now own 4.01% of total outstanding shares. There are both legal and illegal types of insider trading.and more »
05/20/16 12:09 PMBroker Roundup For Cardiovascular Systems, Inc. (NASDAQ:CSII) - Share Trading News - Broker Roundup For Cardiovascular Systems, Inc. (NASDAQ:CSII)Share Trading News10/31/2013 – Cardiovascular Systems, Inc. had its “buy” rating reiterated by analysts at Dougherty & Co. They now have a USD 50 price target on the stock. The share price of Cardiovascular Systems, Inc. (NASDAQ:CSII) was up +1.10% during the last ...and more »
05/18/16 12:32 PMRevenue Update on Cardiovascular Systems Inc(NASDAQ:CSII) - Trade Calls - Revenue Update on Cardiovascular Systems Inc(NASDAQ:CSII)Trade CallsCardiovascular Systems Inc(NASDAQ:CSII) announced the earnings results for Fiscal Year 2016 and Q3. The results came in during After-hours on May 4, 2016. Company reported revenue of $44.46M. Analysts estimated a revenue of $42.13M. Earnings per ...Cardiovascular Systems, Inc. (NASDAQ:CSII) Updated Broker Price TargetsShare Trading NewsWere Analysts Bullish Cardiovascular Systems Inc (NASDAQ:CSII) This Week?Franklin IndependentLatest Analyst Reports On Cardiovascular Systems, Inc.Risers & Fallersall 4 news articles »
05/17/16 12:45 PMNext Weeks Broker Price Targets For Cardiovascular Systems, Inc. (NASDAQ:CSII) - Share Trading News - Next Weeks Broker Price Targets For Cardiovascular Systems, Inc. (NASDAQ:CSII)Share Trading News05/05/2016 – Cardiovascular Systems, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 20 price target on the stock. 12/23/2015 – Northcoast Research began new coverage on Cardiovascular Systems, Inc. giving ...Current Price Targets For Cardiovascular Systems, Inc. (NASDAQ:CSII)Risers & FallersCardiovascular Systems Incorporated (NASDAQ:CSII) Short Interest Decreased By 8.78%Wall Street Hints and Newsall 5 news articles »
05/14/16 06:07 AMCardiovascular Systems Inc. (CSII) Drops 5.55% on May 12 - Equities.com - Cardiovascular Systems Inc. (CSII) Drops 5.55% on May 12Equities.comCardiovascular Systems Inc. (CSII) was one of the Russell 2000's biggest losers for Thursday May 12 as the stock slid 5.55% to $14.30, a loss of $-0.84 per share. Starting at an opening price of $15.20 a share, the stock traded between $14.15 and $15 ...and more »
05/13/16 12:04 PMCARDIOVASCULAR SYSTEMS INC Financials -
05/13/16 06:19 AMUpdated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc. - PR Newswire (press release) - Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.PR Newswire (press release)NEW YORK, May 12, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company") (NASDAQ: CSII), concerning whether the board has ...Cardiovascular Systems Inc to Post FY2016 Earnings of ($1.77) Per Share, William Blair Forecasts (CSII)NewsWay 21How Analysts Rated Cardiovascular Systems Inc (NASDAQ:CSII) Last Week?The PostCardiovascular Systems Inc Forecasted to Post FY2016 Earnings of ($1.78) Per Share (CSII)Web Breaking NewsRealistInvestor.com -Vanguard Tribuneall 6 news articles »
05/12/16 04:28 PMCARDIOVASCULAR SYSTEMS INC Files SEC form 8-K, Other Events -
05/12/16 12:07 PMUpdated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc. - [PR Newswire] - NEW YORK, May 12, 2016 /PRNewswire/ -- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company") ...
05/12/16 06:29 AMPerformance Recap and Target Perspective on Cardiovascular Systems, Inc. (NASDAQ:CSII) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Cardiovascular Systems, Inc. (NASDAQ:CSII)B.O.D.Y ConfidentialSome investors may pay more attention to short short-term share performance, while others may be more interested in stock action over a longer period of time. In the latest trading session, shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) moved -2 ...and more »
05/07/16 05:56 AMCardiovascular Systems Inc. (CSII) Jumps 10.83% on May 05 - Equities.com - Web Breaking NewsCardiovascular Systems Inc. (CSII) Jumps 10.83% on May 05Equities.comCardiovascular Systems Inc. (CSII) was among the biggest gainers on the Russell 2000 for Thursday May 05 as the stock popped 10.83% to $15.15, representing a gain of $1.48 per share. Some 712,521 shares traded hands on 5,439 trades, compared with ...Cardiovascular Systems Inc (NASDAQ:CSII)'s Company Shares Increased 0.15% After Low VolatilityFranklin IndependentCardiovascular Systems, Inc. (NASDAQ:CSII) Latest Broker ViewsRisers & FallersCardiovascular Systems Inc (CSII) Trading Up 10.7% Following Earnings BeatWeb Breaking NewsB.O.D.Y Confidential -Minneapolis / St. Paul Business Journal -StreetInsider.comall 13 news articles »
05/06/16 03:11 PMCARDIOVASCULAR SYSTEMS INC Files SEC form 10-Q, Quarterly Report -
05/06/16 06:15 AMCardiovascular Systems' (CSII) CEO Scott Ward on Q3 2016 Results - Earnings Call Transcript - Good afternoon. My name is Andrew and I will be your conference operator today. At this time, I would like to welcome everyone to the Cardiovascular Systems, Inc. Fiscal 2016 Third Quarter Earnings Conference Call. All lines have been placed on mute to ...
05/05/16 01:00 PMFormer Cardiovascular Systems CEO David Martin dies at 51 -
05/05/16 08:36 AMCardiovascular (CSII) Narrows Loss in Q3, Revenues Beat -
05/05/16 07:11 AMCardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting - [at noodls] - Diamondback 360 Coronary Orbital Atherectomy System (OAS) demonstrates 7.8% Three-Year TLR Rate (ORBIT II; U.S.) ST. PAUL, Minn. & ORLANDO, Fla.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: ...
05/05/16 06:08 AMAverage Analyst Rating for Cardiovascular Systems, Inc. (NASDAQ:CSII) - B.O.D.Y Confidential - Average Analyst Rating for Cardiovascular Systems, Inc. (NASDAQ:CSII)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 2.17 on Cardiovascular Systems, Inc. (NASDAQ:CSII) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks ...and more »
05/05/16 02:03 AMEdited Transcript of CSII earnings conference call or presentation 4-May-16 8:45pm GMT -
05/04/16 05:06 PMCardiovascular Systems reports 3Q loss -
05/04/16 03:19 PM4:19 pm Cardiovascular Systems beats by $0.13, beats on revs; guides Q4 EPS above consensus, revs above consensus -
05/04/16 03:15 PMCARDIOVASCULAR SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an -
05/04/16 03:10 PMCardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial Results - [at noodls] - Conference Call Scheduled for Today, May 4, 2016, at 3:45 PM CT (4:45 PM ET) Revenues of $44.5 million grew 7% from second quarter of fiscal 2016 Gross margin increased to 80.4% from 77.8% in the prior-year ...
05/04/16 06:07 AMQ3 2016 Cardiovascular Systems Inc Earnings Release - After Market Close -
05/03/16 05:54 AMShort Interest Declines 10.2% For CSII - The most recent short interest data has been released for the 04/15/2016 settlement date, which shows a 320,918 share decrease in total short interest for Cardiovascular Systems, Inc (CSII), to 2,813,702, a decrease of 10.24% since 03/31/2016. Total short ...
04/28/16 06:06 AMCardiovascular Systems, Inc. (NASDAQ:CSII) Share Rating Recap - B.O.D.Y Confidential - Cardiovascular Systems, Inc. (NASDAQ:CSII) Share Rating RecapB.O.D.Y ConfidentialShares of Cardiovascular Systems, Inc. (NASDAQ:CSII) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...and more »
04/27/16 10:44 AMBoston Scientific (BSX) Tops Q1 Earnings, Raises Guidance -
04/27/16 07:03 AMCan The Uptrend Continue for Cardiovascular Systems (CSII)? -
04/26/16 06:37 AMCardiovascular Systems, Inc. (NASDAQ:CSII) Wall Street Rating in Focus - News Tribune - Cardiovascular Systems, Inc. (NASDAQ:CSII) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 5 equity research firms that cover shares of Cardiovascular Systems, Inc.and more »
04/26/16 06:37 AMHow Many Cardiovascular Systems Inc (NASDAQ:CSII)'s Analysts Are Bullish? - The Post - How Many Cardiovascular Systems Inc (NASDAQ:CSII)'s Analysts Are Bullish?The PostOut of 6 analysts covering Cardiovascular Systems (NASDAQ:CSII), 5 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 71% are positive. Cardiovascular Systems has been the topic of 12 analyst reports since August 6, 2015 according to ...and more »
04/26/16 06:37 AMCardiovascular Systems, Inc. (NASDAQ:CSII) Share Rating Recap - The Post - Cardiovascular Systems, Inc. (NASDAQ:CSII) Share Rating RecapThe PostShares of Cardiovascular Systems, Inc. (NASDAQ:CSII) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...and more »
About Cardiovascular Systems

Cardiovascular Systems logoCardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee. Its products include Stealth 360 degree Peripheral Orbital Atherectomy System (OAS); the Diamondback 360 Peripheral OAS (Diamondback 360 Peripheral), and Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral OAS and Diamondback 360 4 French 1.25 Peripheral (collectively called as peripheral arterial disease systems (PAD systems)). Its coronary product, the Diamondback 360 Coronary OAS (CAD System), is a catheter-based platform designed to facilitate stent delivery in patients with coronary arterial disease (CAD). The CAD System design is customized for the coronary application.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CSII
  • CUSIP: 14161910
Key Metrics:
  • Previous Close: $17.37
  • 50 Day Moving Average: $16.74
  • 200 Day Moving Average: $13.03
  • P/E Ratio: N/A
  • P/E Growth: -0.41
  • Market Cap: $567.53M
  • Current Quarter EPS Consensus Estimate: $-1.75 EPS
Additional Links:
Cardiovascular Systems (NASDAQ:CSII) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha